STUDresearch · Non-peptide
Low-Dose Naltrexone
Also known as
LDN · naltrexone low dose
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Non-peptide
Some talk
Systemic
Oral
Immune / antimicrobial
Systemic low-dose opioid antagonist immunomodulation lore.
What people say
Low-dose naltrexone is oral naltrexone used at much smaller amounts than the approved 50 mg addiction-treatment tablet. Its off-label immune, pain and fatigue uses are distinct claims, not a different molecule.
Doses people talk about
These are uncontrolled self-reports. The 50 mg approved-tablet label supplies identity and PK context but does not validate an off-label LDN amount or indication.
How it may feel
Actual reports conflict. One six-month 1.5–4.5 mg diary began with fatigue, fog and GI symptoms, had intermittent better periods, and ended with no net benefit; other 0.5–1.5 mg reports described either immediate insomnia or briefly improved sleep followed by nightmares and insomnia.
Six-month same-author diary1.5 → 2 → 2.5 → 3 → 4.5 mg oral nightly
The author later reduced to 3 mg and 1.5 mg and concluded there was no net benefit after about six months; the sequence is history, not a progression recommendation.
Single-dose insomnia report0.5 mg once at about 5 pm; route and formulation unstated
A commenter reported no sleep that night and new limb and joint pain; one dose cannot establish causality or a usual response.
Twelve-day sleep report1.5 mg oral daily
The user moved dosing to night after fatigue, first slept unusually well, then reported vivid nightmares and insomnia by days 8–12.
Half-life & effect duration
- Half-life in the body
- Naltrexone · oral labelAbout 4 hours
- Active metabolite · 6-beta-naltrexolAbout 13 hours
- Felt duration people report
- First-night reportsInsomnia or better sleep
- Longer accountsFluctuating symptoms over months; one 6-month diary ended with no net benefit
Cycles people discuss
The inspected accounts used consecutive oral doses for 12 days or roughly six months. Neither supports a standard weeks-on/weeks-off cycle, and the longer diary changed amounts repeatedly before stopping.
Timing
Nightly oral use is common in the notes, but sleep response varies: some report good sleep, while others report insomnia or vivid dreams after evening dosing. These reports do not establish night as universally better.
Stacks
Lifestyle changes and multi-agent use make attribution harder. The inspected long diary itself noted sugar, gluten, exercise, illness and other care as competing explanations.
Watch for
Do not combine carelessly with opioids: Precipitated withdrawal risk.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
The oral-tablet label reports a 4-hour mean half-life for parent naltrexone and 13 hours for its major metabolite 6β-naltrexol.
The label also reports peak plasma levels within about one hour and substantial first-pass metabolism.
The label's dose-proportional data cover 50–200 mg, so these PK values are formal identity context rather than direct proof of kinetics at 0.5–4.5 mg LDN.
- DailyMed — Naltrexone hydrochloride 50 mg tablets (opens in a new tab)Pharmacokinetics section: oral absorption, peak within one hour, 5–40% bioavailability, and mean elimination half-lives of 4 hours for naltrexone and 13 hours for 6β-naltrexol.Approved 50 mg tablet labeling; dose proportionality is described from 50–200 mg, not the off-label low-dose range in the community reports.
Felt duration people report
Felt timing ranged from first-night insomnia or better sleep to fluctuating symptoms over months, and the longest same-author diary ended with no perceived net benefit.
The six-month diary recorded multiple dose changes, illnesses, diet changes and activity changes; the 12-day report changed dose timing after fatigue.
Uncontrolled self-reports, unverified products, changing doses, one unstated route/formulation and major co-occurring factors prevent a usual onset or duration estimate.
- r/LowDoseNaltrexone — My LDN journal (opens in a new tab)Smart-Pen203's original post and dated same-author updates run from days 1–4 through the January 23, 2026 final entry, with 1.5, 2, 2.5, 3 and 4.5 mg nightly then reductions. A separate Tom-Tortuga comment reports one 0.5 mg dose around 5 pm, no sleep that night and new limb/joint pain.Two distinct uncontrolled accounts: the diary changed amounts amid illnesses, diet, exercise and other care; the separate 0.5 mg comment does not state route or formulation. Online product identity was not analytically verified.
- r/LowDoseNaltrexone — Insomnia after 1.5 mg (opens in a new tab)Original report after about 12 days at 1.5 mg: first-week fatigue, temporary sleep improvement after moving dosing to night, then vivid nightmares and difficulty falling and staying asleep.Short uncontrolled report with a planned but not yet completed dose increase; no product verification or objective sleep measures.
What people say
- Pain / autoimmune anecdotes: Large patient communities; evidence quality varies by condition. forum
- Why it trends: Low-Dose Naltrexone is discussed mainly for recovery-related goals in community and secondary sources. forum
- What people claim: Anecdotes range from subtle to dramatic; lifestyle confounds are the rule. anecdote
- Time course: Early days are often side-effect or placebo window; multi-week blocks are the real checkpoint. forum
- Some clinical exploration: Small trials exist for select indications. trial
Doses people talk about
- LDN band: Often ~1.5–4.5 mg oral at night discussed. forum
- Quality flag: Assume label accuracy only if analytically verified — gray market fill error is common. forum
- Observed diary range: One six-month journal recorded oral nightly amounts from 1.5 to 4.5 mg, followed by reductions; the author ultimately reported no net benefit. forum
- Product quality: Gray-market fill accuracy and identity are uncertain; dose math assumes the label is true. forum
- Route boundary: The reviewed LDN reports and formal PK source concern oral naltrexone; SC and nasal LDN equivalence was not established. forum
- Not full naltrexone block dose: Much lower than addiction-medicine doses. trial
- Framing: All figures are discussed trial, clinic, or community amounts — research/educational only, not prescriptions. forum
How it may feel
- Days 1–7: In one 1.5 mg nightly diary, early grogginess, brain fog, stomach ache and fatigue varied day to day; the same author later reported transient improvement, then no net benefit after about six months. forum
- Weeks 2–8: Common “wait for LDN effect” window in forums. forum
- Sleep can move either way: One person reported no sleep after a single 0.5 mg evening dose; another at 1.5 mg described several nights of unusually good sleep before vivid nightmares and insomnia. forum
- Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
- Weeks 1–2: First honest checkpoint in self-logs. forum
Cycles people discuss
- Ongoing nightly: Common. forum
- Observed courses: The reviewed journal described nightly use across about six months with dose changes; another report described 12 consecutive days. These accounts do not establish a universal cycle. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Night dosing culture: Opioid receptor transient blockade hypothesis. forum
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- Published PK: Where human PK exists it should override forum half-life memes for Low-Dose Naltrexone. trial
More on what it is
- What it is: Naltrexone at low nightly mg doses (LDN) discussed for immune modulation, pain, and autoimmune lore — distinct from full-dose addiction dosing. forum
- See also: Catalog may also list LDN under shorter slug. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- How people talk about it: Forum volume is a popularity signal for Low-Dose Naltrexone, not proof it works for you. forum
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- With anti-inflammatory lifestyle: Confounded. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Vivid dreams / insomnia: Classic early LDN. forum
- Oral tolerability reports: Sleep disruption, vivid dreams, fatigue, GI symptoms and headache were described; injection-site wording does not fit the reviewed oral LDN context. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
- Do not combine carelessly with opioids: Precipitated withdrawal risk. trial
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.